Two drugs worked together against brain tumor cells in the lab
Original title: MLN4924 Enhances RSL3-Induced Ferroptosis Sensitivity in Glioblastoma via Inhibiting the STAT3/GPX4 Axis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in lab cells and in animals, not in people with brain tumors.
The short version
In lab and animal tests, pairing two drugs made brain tumor cells die more easily.
What was studied. Researchers tested a drug called MLN4924, also known as pevonedistat, on glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. They used it alone and with a second drug called RSL3, in lab cells and in animals with tumors under the skin.
What they found. MLN4924 pushed tumor cells into a kind of cell death that uses iron. It did this by lowering a protein called GPX4, which normally protects cells from that death. RSL3 blocked GPX4 in a different way, and using both drugs together killed more cells and slowed tumor growth in animals.
What this means, and what it doesn't
What it could mean: This points to GPX4 as a possible target in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. It also suggests a reason to test these two drugs together. For now, it is a lead for future research, not a treatment a doctor can offer.
What it doesn't mean: This does not mean there is a new treatment for people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. The work was done in cells and in animals, not in people with brain tumors. Tumors grown under the skin in animals are not the same as a tumor in the brain. Many drugs that work in these tests do not work in people. This is not a cure, and it is a long way from everyday care.
Source: PubMed, August 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.